UKLF/PCBP2 axis governs the colorectal cancer development by transcriptionally activating SLC39A4

Yunze Li1, Lina Liu1

  • 1Department of General Surgery, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang 110004, China.

Insights

Ubiquitous Kruppel-like factor (UKLF) drives colorectal cancer (CRC) growth and spread. Targeting the PCBP2/UKLF/SLC39A4 pathway offers a potential new strategy for CRC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) presents significant treatment challenges.
  • New therapeutic targets for CRC are urgently needed.
  • The role of Ubiquitous Kruppel-like factor (UKLF) in CRC is not fully understood.

Purpose of the Study:

  • To investigate the function and molecular mechanism of UKLF in colorectal cancer development.
  • To explore the potential of UKLF as a therapeutic target for CRC.

Main Methods:

  • Analysis of UKLF expression in clinical CRC tissues.
  • In vitro assays assessing cell proliferation, migration, invasion, and apoptosis.
  • In vivo tumor growth studies.
  • Investigation of regulatory mechanisms involving PCBP2 and SLC39A4.

Main Results:

  • UKLF was highly expressed in CRC tissues and correlated with poor prognosis.
  • UKLF promoted CRC cell proliferation, migration, and invasion while inhibiting apoptosis.
  • UKLF accelerated tumor growth in vivo.
  • PCBP2 enhances UKLF mRNA stability by binding to its 3'-UTR.
  • UKLF regulates SLC39A4 expression transcriptionally.

Conclusions:

  • UKLF plays a critical role in promoting CRC progression.
  • The PCBP2/UKLF/SLC39A4 pathway is crucial in CRC development.
  • Targeting UKLF represents a promising novel therapeutic strategy for colorectal cancer.

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.6K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K